How is pulmonary embolism treated? 

Treatment for a pulmonary embolism (PE) in the UK follows a strict clinical pathway designed to thin the blood, prevent the clot from growing, and reduce the risk of future blockages. Most patients are treated with anticoagulant medications, such as Direct Oral Anticoagulants (DOACs) or heparin injections. If the embolism is severe and life-threatening, emergency treatments like thrombolysis (clot-busting medicine) or surgery may be required to quickly dissolve or remove the obstruction from the lungs. 

What We will cover in this Article 

• The use of anticoagulants like apixaban and rivaroxaban 

• Emergency interventions for high-risk pulmonary embolisms 

• How heparin injections provide immediate protection 

• The duration of treatment and the role of clinical reviews 

• Understanding the causes and triggers of lung clots 

• Differentiating PE treatment from standard DVT care 

• Essential safety advice and identifying emergency symptoms 

Initial and long-term anticoagulant therapy 

The cornerstone of PE treatment is anticoagulation. According to NICE guidelines, most patients who are hemodynamically stable are started on DOACs. These medications, such as apixaban or rivaroxaban, are typically initiated at a higher loading dose for the first few weeks to stabilize the clot and prevent it from breaking apart further. Unlike older treatments, DOACs do not require regular blood monitoring and start working almost immediately. 

In some cases, or for patients who are initially very unwell, low molecular weight heparin (LMWH) injections are used. These are administered once or twice a day into the abdomen. If you are pregnant or have certain types of cancer, injections might be the preferred long-term treatment. Once the initial risk has passed, most patients transition to a maintenance dose of a tablet-based blood thinner for a minimum of three to six months. 

Emergency treatments for severe cases 

When a pulmonary embolism is so large that it blocks significant blood flow and causes a dangerous drop in blood pressure, it is classified as a ‘high-risk’ or ‘massive’ PE. In these life-threatening situations, standard blood thinners may not be fast enough. Clinicians may instead use thrombolysis, which involves injecting powerful ‘clot-busting’ drugs directly into a vein to rapidly dissolve the obstruction. 

If thrombolysis is not safe for example, if the patient has a high risk of internal bleeding a procedure called a thrombectomy may be performed. This is a specialist surgery where a thin tube (catheter) is guided through the blood vessels to the lungs to physically break up or pull out the clot. While highly effective, these interventions are usually reserved for critical care or intensive care settings. 

Causes of pulmonary embolism 

A pulmonary embolism is rarely an isolated event; it is almost always a complication of a blood clot that formed elsewhere, usually in the deep veins of the legs (DVT). Understanding why the clot formed is a vital part of the treatment plan, as it helps doctors decide how long you need to stay on medication. Identifying the cause also helps in preventing a recurrence. 

Primary causes include: 

• Deep vein thrombosis (DVT): Where a piece of a leg clot breaks off and travels to the lungs. 

• Underlying health conditions: Such as heart disease, lung disease, or certain cancers. 

• Inherited blood disorders: Conditions that make the blood naturally ‘stickier’ and more prone to clotting. 

• Damage to blood vessel walls: Caused by previous injury or chronic inflammation. 

Triggers for lung clots 

Triggers are the situational factors that lead to the formation of the initial clot. By identifying these, medical teams can provide tailored advice on how to avoid another PE in the future. During your recovery, you will be advised on how to manage these triggers, especially if you have a job or lifestyle that involves high-risk activities. 

Common triggers include: 

• Major surgery: Particularly operations on the hip, knee, or abdomen. 

• Prolonged inactivity: Such as long-distance flights or being bedridden due to illness. 

• Hormonal factors: Use of the combined contraceptive pill, HRT, or pregnancy. 

• Lifestyle factors: Severe dehydration, obesity, and smoking all contribute significantly to the risk. 

PE vs. DVT: Differences in treatment 

While the medications used for PE and DVT are often the same, the intensity of monitoring and the initial management are different. A pulmonary embolism is considered a more serious condition because it affects heart and lung function. Patients with a PE often require a short hospital stay for observation, oxygen therapy, and sometimes heart scans (echocardiograms) to ensure the heart is not under too much strain. 

In contrast, most DVT patients can be managed entirely as outpatients. The treatment for PE also places a greater emphasis on identifying symptoms like shortness of breath or chest pain. If you have had a PE, your follow-up care will focus heavily on lung recovery and ensuring your exercise tolerance returns to normal, whereas DVT follow-up focuses more on limb health and preventing long-term leg swelling. 

Conclusion 

Pulmonary embolism treatment in the UK is highly structured and effective, focusing on rapid anticoagulation to prevent further complications. Whether you are managed with daily tablets or require emergency hospital intervention, the goal is to protect your lungs and heart while the body heals. Following your medication plan and attending all follow-up reviews is essential for a safe and full recovery. 

If you experience severe, sudden, or worsening symptoms, such as difficulty breathing or sharp chest pain, call 999 immediately. 

Authority Snapshot 

This article provides a medically safe overview of pulmonary embolism management within the UK healthcare system. It aligns with NICE guideline NG158 and the clinical pathways used in NHS acute trusts. The content is designed to help patients understand their treatment options and the importance of medication adherence for long-term health. Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.